Dickerson Matthew, Leong Kristen, Sheldon Kate, Madison Lara
Biomarker Division, BioScale, Inc.
J Vis Exp. 2011 Feb 3(48):2493. doi: 10.3791/2493.
Custom assays for unique proteins are often limited to time consuming manual detection and quantitation techniques such as ELISA or Western blots due to the complexity of development on alternate platforms. BioScale's proprietary Acoustic Membrane MicroParticle (AMMP) technology allows sandwich immunoassays to be easily developed for use on the ViBE platform, providing better sensitivity, reproducibility, and automated operation. Provided as an example, this protocol outlines the procedure for developing a custom Chinese Hamster Ovary- Host Cell Protein (CHO-HCP) assay. The general principles outlined here can be followed for the development of a wide variety of immunoassays. An AMMP assay measures antigen concentration by measuring changes in oscillation frequency caused by the binding of microparticles to the sensor surface to calculate. It consists of four major components: (1) a cartridge that contains a functionalized eight sensor chip (2) antibody labeled magnetic microparticles, (3) hapten tagged antibody that binds to the surface of the functionalized chip (4) samples containing the antigen of interest. BioScale's biosensor is a resonant device that contains eight individual membranes with separate fluidic paths. The membranes change oscillation frequency in response to mass accumulating on the surface and this frequency change is used to quantitate the amount of added mass. To facilitate use in a wide variety of immunoassays the sensor is functionalized with an anti-hapten antibody. Assay specific antibodies are modified through the covalent conjugation of a hapten tag to one antibody and biotin to the other. The biotin label is used to bind the antibody to streptavidin coupled magnetic beads which, in combination with the hapten-tagged antibody, are used to capture the analyte in a sandwich. The complex binds to the chip through the anti-hapten/hapten interaction. At the end of each assay run the sensors are cleaned with a dilute acid enabling the sequential analysis of columns from a 96-well plate. Here, we present the method for developing a custom CHO-HCP AMMP assay for bioprocess development. Developing AMMP assays or modifying existing assays into AMMP assays can provide better performance (reproducibility, sensitivity) in complex samples and reduced operator time. The protocol shows the steps for development and the discussion section reviews representative results. For a more in-depth explanation of assay optimization and customization parameters contact BioScale. This kit offers generic bioprocess development assays such as Residual Protein A, Product titer, and CHO-HCP.
由于在其他平台上开发的复杂性,针对独特蛋白质的定制检测方法通常仅限于耗时的手动检测和定量技术,如酶联免疫吸附测定(ELISA)或蛋白质免疫印迹法。BioScale公司专有的声学膜微粒(AMMP)技术使夹心免疫测定能够轻松地在ViBE平台上开发使用,具有更好的灵敏度、重现性和自动化操作。作为示例,本方案概述了开发定制的中国仓鼠卵巢宿主细胞蛋白(CHO-HCP)检测方法的步骤。这里概述的一般原则可用于开发各种免疫测定。AMMP检测通过测量微粒与传感器表面结合引起的振荡频率变化来计算抗原浓度。它由四个主要部分组成:(1)一个包含功能化的八传感器芯片的试剂盒,(2)抗体标记的磁性微粒,(3)与功能化芯片表面结合的半抗原标记抗体,(4)含有目标抗原的样品。BioScale的生物传感器是一种共振装置,包含八个具有独立流体路径的单个膜。膜会响应表面积累的质量而改变振荡频率,这种频率变化用于定量添加的质量量。为便于在各种免疫测定中使用,传感器用抗半抗原抗体进行功能化。检测特异性抗体通过将半抗原标签共价偶联到一种抗体上,将生物素偶联到另一种抗体上进行修饰。生物素标签用于将抗体与链霉亲和素偶联的磁珠结合,磁珠与半抗原标记的抗体一起用于在夹心中捕获分析物。复合物通过抗半抗原/半抗原相互作用与芯片结合。在每次检测运行结束时,用稀酸清洗传感器,从而能够对96孔板中的各列进行顺序分析。在此,我们展示了为生物工艺开发开发定制的CHO-HCP AMMP检测方法的方法。开发AMMP检测方法或将现有检测方法修改为AMMP检测方法可在复杂样品中提供更好的性能(重现性、灵敏度)并减少操作人员时间。该方案展示了开发步骤,讨论部分回顾了代表性结果。如需更深入地解释检测优化和定制参数,请联系BioScale。该试剂盒提供通用的生物工艺开发检测方法,如残留蛋白A、产品效价和CHO-HCP。